A trial carried out in Italy in 2021 analyzed the bacteria population found in turkey feces. Two sampling points were used, at 21 and 85 days, taking a different taxonomic level (from phylum to species) by 16S sequencing. This was to define the impact of Safmannan® on the microbial population.
The graphs show at each classification level, that Safmannan® helps increase the beneficial bacteria population while reducing the harmful bacteria.
The control group results show a colonisation by Proteobacteria (Enterobacteriales, Campylobacteriales, Pseudomonales). This did not occur in the Safmannan® group.
In the Safmannan® group, there was a greater abundance of beneficial micro-organisms, such as Lactobacillus spp and Clostridium, mainly bifermentans (1,96% vs 0,51).